Navigation Links
Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance

Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years... -- ABBOTT PARK, Ill., Sept. 9 /PRNewswire-FirstCall/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, Corporate Social Responsibility Click to view news release full screen  

Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance


Abbott Leads the Industry in Environmental Management and Climate Policy, Responsible Marketing Practices, Standards for Suppliers, Innovative Philanthropy

ABBOTT PARK, Ill., Sept. 9 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) announced today that it was included on both the Dow Jones Sustainability World Index and North America Index for the sixth consecutive year.  The Dow Jones Sustainability Indexes (DJSI) recognize the leading companies in each industry sector for responsible economic, environmental and social performance.

Abbott was named the industry leader in several categories, including a score of 100 percent in environmental management and climate strategy, key areas of focus in the company's comprehensive effort to safeguard the environment.  Abbott also led the industry in responsible marketing practices, standards for suppliers, innovative philanthropy, and employee health and safety.

Abbott is one of only two U.S.-based companies in its industry sector to be listed on both the North America and World Indexes.  The company's overall score of 84 percent is significantly higher than the average score of 53 percent for other companies in the sector.

Abbott's scores increased in 19 of 23 categories compared to the previous year, demonstrating its ongoing commitment to continuous improvement in citizenship and sustainability.  This included significant improvement in the company's efforts to improve patient health outcomes, and strengthen risk and crisis management.  

"The environments in which we operate – natural, social, economic and political – are particularly sensitive and challenging, requiring companies like Abbott to be more thoughtful than ever about the ways we operate our business," said Miles D. White, chairman and chief executive officer, Abbott.  "We believe that Abbott has met that challenge, across the spectrum of its business activities."

As a member of the prestigious Dow Jones Sustainability World Index, Abbott is among the top 300 of the 2,500 largest companies worldwide in terms of sustainability. The DJSI annual review considers sustainability leaders from each industry on a global and regional level, and involves thorough analyses of corporate governance, risk management, branding, climate change mitigation, supply chain standards, labor practices and related citizenship issues.

About Abbott's Approach to CitizenshipGlobal citizenship is an integral part of Abbott's mission to improve people's lives, focused on four key areas:  innovating for the future, enhancing access to health care, protecting patients and consumers, and safeguarding the environment.  Working in partnership with others, Abbott leverages its core business expertise and resources to create sustainable solutions in countries around the world.

In addition to being included in the Dow Jones Sustainability Indexes, Abbott ranked sixth overall on the global "100 Best Corporate Citizens List 2010" compiled by Corporate Responsibility magazine.  The company was named one of the top three "2010 Best in Class" companies in its industry sector by Storebrand Investments, a leading socially responsible investment (SRI) firm.

FORTUNE magazine also named Abbott the No. 1 Most Admired Company in its industry sector in 2010, in part for the company's strong performance in social responsibility.  In addition to these global honors, Abbott has been recognized for its sustainability efforts in countries around the world, including Brazil, China, Denmark, Finland, Ireland, Italy, Korea, Mexico, Singapore, Tanzania and the United States.  

To learn more about Abbott's sustainability initiatives and to read or download the company's 2009 global citizenship report, please visit

About Abbott Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at


Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Abbott Completes Acquisition of Piramals Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India
2. Abbott Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment
3. Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference
4. Abbotts SIMCOR ® ( niacin extended-release / simvastatin ) Receives FDA Approval for New Dosage Strengths
5. Abbott to Feature Novel Tests and New Upgrades to Testing Platforms at American Association for Clinical Chemistry Lab Expo
6. Abbott Receives FDA Clearance for Molecular Diagnostic Test for Detection of Chlamydia and Gonorrhea Infections
7. Abbott to Present Data on Several Investigational Cancer Treatments at American Society of Clinical Oncology Annual Meeting
8. The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbotts Carotid Stent System and Surgery
9. Abbotts Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results
10. Abbotts Investigational MitraClip(R) System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves
11. New Data Reinforces Safety Profile of Abbotts Market-Leading XIENCE V(R) Drug Eluting Stent
Post Your Comments:
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):